Data protection Impressum

Financing

Swiss start-ups raised CHF 1.47 billion in the first half of 2025, with biotech and fintech driving growth despite fewer deals and cautious investor sentiment.

Business environment

Swiss start-ups attract CHF 1.47 billion in first half of 2025

15 July 2025

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

CREAL has raised USD 8.9 million to boost AR and vision care tech with ZEISS, advancing light field displays for immersive, eye-friendly digital experiences.

CREAL raises USD 8.9 million to advance AR and vision care innovation

14 July 2025

Adiposs secures CHF 4 million to advance ImageBAT, a novel contrast agent using CT scans to predict cancer treatment response via brown fat imaging.

Adiposs raises CHF 4 million to advance brown fat imaging in cancer care

1 July 2025

Backed by public funding and growing clinical interest, AirScale's sensor-based technology aims to simplify hospital workflows and improve patient care.

Bern-based medtech AirScale develops smart weighing solution for immobile patients

23 June 2025

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

With continued leadership in government efficiency and infrastructure, Switzerland has been named the world’s most competitive economy in the 2025 edition of the IMD World Competitiveness Ranking.

Switzerland tops IMD’s 2025 World Competitiveness Ranking

17 June 2025

Start-ups Aseptuva, Bloom Biorenewables, and Hafnova have been selected for multi-year EU-funded projects, reinforcing Western Switzerland’s importance in health tech, sustainable chemistry and cybersecurity.

Three rising Western Switzerland start-ups join major European innovation programs

3 June 2025

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

1 2 3 4 5 … 32